Palvella Therapeutics Ownership & Insider Activity

Palvella Therapeutics (PVLA) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 2.7% of shares outstanding. Institutional investors hold 51.7%.

Shares Outstanding

14.408M

Shares Float

12.738M

Insider Shares Owned

393.385K

Insider % Owned

2.7%

Institutional Shares Held

7.453M

Institutional % Held

51.7%

Ownership Breakdown

Net Insider Activity by Month

Palvella Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 2, 2026	CHRISTOPHER KIRITSY	DIRECTOR	SELL-OPTIONS	—	$142.10	$9K
Aug 19, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$80.16	$620K
Jul 15, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$78.69	$607K
Jun 17, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$59.42	$441K
May 20, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$59.33	$441K
Apr 15, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$67.68	$513K
Mar 30, 2026	GEORGE JENKINS	DIRECTOR	BUY	445.000	$112.30	$50K
Mar 18, 2026	Kathleen A. McGowan Attorney-in-Fact	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$63.05	$473K